Roche Holding AG
SIX:ROG
Roche Holding AG
Operating Expenses
Roche Holding AG
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Operating Expenses
-CHf24.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Novartis AG
SIX:NOVN
|
Operating Expenses
-$22B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Operating Expenses
-$15.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Operating Expenses
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Operating Expenses?
Operating Expenses
-24.6B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Operating Expenses amounts to -24.6B CHF.
What is Roche Holding AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-4%
Over the last year, the Operating Expenses growth was 1%. The average annual Operating Expenses growth rates for Roche Holding AG have been -2% over the past three years , -3% over the past five years , and -4% over the past ten years .